Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preeclampsia Intervention 4 - A Triple Blind Phase III Randomised Controlled Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

NCT06033131 is registered in ClinicalTrials.gov with Lina Bergman as lead sponsor.

NCT NCT06033131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06033131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preeclampsia Intervention 4 - A Triple Blind Phase III Randomised Controlled Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
Lead sponsor
Lina Bergman
Phase
Phase 3
Overall status
Recruiting
Start date
January 19, 2024
Completion date
December 31, 2029
Enrollment
294 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia